Trifluridin/tipiracil in treatment of refractory metastatic colorectal cancer – early clinical experience
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Žitňanská L. | cs |
dc.contributor.author | Donátová Z. | cs |
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Veškrňová Veronika | cs |
dc.contributor.author | Buchler Tomáš | cs |
dc.contributor.author | Abrahámová Jitka | cs |
dc.date.accessioned | 2018-09-25T12:15:53Z | |
dc.date.available | 2018-09-25T12:15:53Z | |
dc.date.issued | 2017 | cs |
dc.format.extent | 4 | cs |
dc.identifier.issn | 1802-4475 | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/31454 | |
dc.language.iso | cze | cs |
dc.publisher | Solen | cs |
dc.publisher.city | Olomouc | cs |
dc.relation.ispartofseries | 2 | cs |
dc.relation.uri | https://www.onkologiecs.cz/artkey/xon-201702-0008_Trifluridin_tipiracil_v_lecbe_pacientu_s_refrakternim_metastatickym_kolorektalnim_karcinomem_8211_prvni_klin.php | cs |
dc.subject | colorectal cancer | cs |
dc.subject | trifluridin/tipiracil | cs |
dc.subject | progression free survival | cs |
dc.subject | overall survival. | cs |
dc.title | Trifluridin/tipiracil in treatment of refractory metastatic colorectal cancer – early clinical experience | en |
dc.title | Trifluridin/tipiracil v léčbě pacientů s refrakterním metastatickým kolorektálním karcinomem-první klinické zkušenosti | cs |
local.citation.epage | 88-91 | cs |
local.citation.spage | 88-91 | cs |
local.identifier.publikace | 4917 | |
local.relation.issue | 11 | cs |